carvacrol has been researched along with Osteogenic Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, X; He, L; Hu, X; Jiao, Q; Jin, S; Li, X; Liang, W; Shang, J; Xu, Y; Zhang, S | 1 |
1 other study(ies) available for carvacrol and Osteogenic Sarcoma
| Article | Year |
|---|---|
Carvacrol Suppresses Human Osteosarcoma Cells via the Wnt/β-Catenin Signaling Pathway.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cymenes; Humans; Osteosarcoma; Phenols; Wnt Signaling Pathway | 2022 |